Avadel Pharmaceuticals plc AWK1.F Stock
Avadel Pharmaceuticals plc Price Chart
Avadel Pharmaceuticals plc AWK1.F Financial and Trading Overview
| Avadel Pharmaceuticals plc stock price | 14.3 EUR |
| Previous Close | 10.5 EUR |
| Open | 10.5 EUR |
| Bid | 12.6 EUR x 0 |
| Ask | 13.3 EUR x 0 |
| Day's Range | 10.5 - 10.5 EUR |
| 52 Week Range | 2.12 - 10.5 EUR |
| Volume | 25 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 1.07B EUR |
| Beta (5Y Monthly) | 1.427112 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.86 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.25 EUR |
AWK1.F Valuation Measures
| Enterprise Value | 820.31M EUR |
| Trailing P/E | N/A |
| Forward P/E | -36.206898 |
| PEG Ratio (5 yr expected) | -0.42 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -8.814 |
Trading Information
Avadel Pharmaceuticals plc Stock Price History
| Beta (5Y Monthly) | 1.427112 |
| 52-Week Change | 390.65% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.5 EUR |
| 52 Week Low | 2.12 EUR |
| 50-Day Moving Average | 9.65 EUR |
| 200-Day Moving Average | 7.46 EUR |
AWK1.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 76.77M |
| Float | 57.2M |
| Short Ratio | N/A |
| % Held by Insiders | 5.21% |
| % Held by Institutions | 45.16% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -32.77% |
| Return on Equity (ttm) | -1662.065% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -93066000 EUR |
| Net Income Avi to Common (ttm) | -141824000 EUR |
| Diluted EPS (ttm) | -2.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 100.92M EUR |
| Total Cash Per Share (mrq) | 1.32 EUR |
| Total Debt (mrq) | 115.16M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.379 |
| Book Value Per Share (mrq) | -0.592 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -66492000 EUR |
| Levered Free Cash Flow (ttm) | 16.72M EUR |
Profile of Avadel Pharmaceuticals plc
| Country | Germany |
| State | N/A |
| City | Dublin |
| Address | 10 Earlsfort Terrace |
| ZIP | 2 |
| Phone | 353 1 901 5201 |
| Website | https://www.avadel.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 41 |
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Q&A For Avadel Pharmaceuticals plc Stock
What is a current AWK1.F stock price?
Avadel Pharmaceuticals plc AWK1.F stock price today per share is 14.3 EUR.
How to purchase Avadel Pharmaceuticals plc stock?
You can buy AWK1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Avadel Pharmaceuticals plc?
The stock symbol or ticker of Avadel Pharmaceuticals plc is AWK1.F.
Which industry does the Avadel Pharmaceuticals plc company belong to?
The Avadel Pharmaceuticals plc industry is Drug Manufacturers-Specialty & Generic.
How many shares does Avadel Pharmaceuticals plc have in circulation?
The max supply of Avadel Pharmaceuticals plc shares is 94.42M.
What is Avadel Pharmaceuticals plc Price to Earnings Ratio (PE Ratio)?
Avadel Pharmaceuticals plc PE Ratio is now.
What was Avadel Pharmaceuticals plc earnings per share over the trailing 12 months (TTM)?
Avadel Pharmaceuticals plc EPS is -1.86 EUR over the trailing 12 months.
Which sector does the Avadel Pharmaceuticals plc company belong to?
The Avadel Pharmaceuticals plc sector is Healthcare.